Advertisement
Screener

Tango Therapeutics, Inc. (TNGX) ROA

Tango Therapeutics, Inc. (TNGX) ROA

  • 2026-06-30: ROA -11.52%.
  • 2026-03-31: ROA -24.61%.
  • 2025-12-31: ROA -25.48%.
  • 2025-09-30: ROA -47.83%.

Complete source-backed roa history.

Available history
2020-12-31 to 2026-06-30
Data captured

Historical ROA

DateROA
2026-06-30-11.52%
2026-03-31-24.61%
2025-12-31-25.48%
2025-09-30-47.83%
2025-06-30-61.19%
2025-03-31-48.22%
2024-12-31-41.17%
2024-09-30-35.01%
2024-06-30-30.54%
2024-03-31-27.48%
2023-12-31-25.27%
2023-09-30-23.36%
2023-06-30-28.16%
2023-03-31-27.48%
2022-12-31-24.78%
2022-09-30-21.79%
2022-06-30-20.45%
2022-03-31-15.13%
2021-12-31-11.64%
2021-09-30-8.50%
2021-06-30-31.19%
2021-03-31-33.38%
2020-12-31-25.08%

Annual ROA

DateROA
2025-12-31-25.48%
2024-12-31-41.17%
2023-12-31-25.27%
2022-12-31-24.78%
2021-12-31-11.64%
2020-12-31-25.08%

Similar stocks

Stock NameCountryMarket CapPE Ratio
Indivior Pharmaceuticals, Inc. (INDV)$4.250B14.09
Viking Therapeutics, Inc. (VKTX)United States$4.287B-8.51
AbCellera Biologics Inc. (ABCL)$3.879B-14.59
Edgewise Therapeutics, Inc. (EWTX)United States$4.470B-22.23
ACADIA PHARMACEUTICALS INC (ACAD)United States$3.823B11.45
Xenon Pharmaceuticals Inc. (XENE)$3.684B-14.27
Organon & Co. (OGN)United States$3.603B17.03
IDEAYA Biosciences, Inc. (IDYA)United States$3.540B-20.52
Veradermics, Inc (MANE)United States$4.839B
Amylyx Pharmaceuticals, Inc. (AMLX)United States$3.361B-13.15